aiqbench analysis
SEISMO represents a significant advancement in sample-efficient molecular optimization by leveraging LLM agents to interpret discarded oracle feedback through natural language and explainability methods. This approach directly addresses the high cost of experimental assays in drug discovery, allowing chemists to steer generation processes while maintaining central oversight over the optimization trajectory. By transforming scalar black-box scores into actionable guidance signals, the method demonstrates improved efficiency across diverse pharmaceutical tasks without relying on zero-shot limitations.
SEISMO: Explanation-Aware, Trajectory-Conditioned LLM Agents for Sample-Efficient Molecular Optimisation
arXiv:2602.00663v3 Announce Type: replace Abstract: Optimizing molecules to achieve desired properties is a central bottleneck across the chemical sciences, particularly in the pharmaceutical industry, where it underlies the discovery of new drugs. Since molecular property evaluation often relies on costly and rate-limited oracles, such as experimental assays, molecular optimization must be highly sample-efficient. To address this, we introduce SEISMO, an LLM agent for inference-time molecular optimisation that turns information routinely available alongside the oracle score, but discarded by existing methods, into an explicit guidance signal. Rather than treating the oracle as a scalar black box, SEISMO conditions each proposal on a natural-language task description, the full optimization trajectory, and machine-readable feedback derived from post-hoc explainability methods and sub-score decompositions. Across a wide range of drug-discovery-relevant tasks, this consistently improves sample efficiency over existing optimisers as well as zero-shot LLM generation, with gains growing as explanatory feedback is enriched. In practice, medicinal chemists can inspect the agent's reasoning and intervene to steer generation in natural language, keeping them central to molecular optimisation projects.
Abstract:Optimizing molecules to achieve desired properties is a central bottleneck across the chemical sciences, particularly in the pharmaceutical industry, where it underlies the discovery of new drugs. Since molecular property evaluation often relies on costly and rate-limited oracles, such as experimental assays, molecular optimization must be highly sample-efficient. To address this, we introduce SEISMO, an LLM agent for inference-time molecular optimisation that turns information routinely available alongside the oracle score, but discarded by existing methods, into an explicit guidance signal. Rather than treating the oracle as a scalar black box, SEISMO conditions each proposal on a natural-language task description, the full optimization trajectory, and machine-readable feedback derived from post-hoc explainability methods and sub-score decompositions. Across a wide range of drug-discovery-relevant tasks, this consistently improves sample efficiency over existing optimisers as well as zero-shot LLM generation, with gains growing as explanatory feedback is enriched. In practice, medicinal chemists can inspect the agent's reasoning and intervene to steer generation in natural language, keeping them central to molecular optimisation projects.
Fabian P. Krüger and Andrea Hunklinger contributed equally to this work
Artificial Intelligence (cs.AI); Machine Learning (cs.LG); Biomolecules (q-bio.BM)
arXiv:2602.00663 [cs.AI]
(or arXiv:2602.00663v3 [cs.AI] for this version)
https://doi.org/10.48550/arXiv.2602.00663 Focus to learn more arXiv-issued DOI via DataCite
arXivLabs is a framework that allows collaborators to develop and share new arXiv features directly on our website.
Both individuals and organizations that work with arXivLabs have embraced and accepted our values of openness, community, excellence, and user data privacy. arXiv is committed to these values and only works with partners that adhere to them.
Have an idea for a project that will add value for arXiv's community? Learn more about arXivLabs.
Full text under the publisher's open licence · 275 words
Related coverage

Frontier AI Risk Report (February–March 2026)
METR · May 19, 2026

Frontier Risk Report (February to March 2026)
METR · May 19, 2026

Informe de riesgos de la IA de frontera (febrero–marzo de 2026)
METR · May 19, 2026
What's Continual Learning, and Why Might We Expect To See It In Advanced LLM Agents?
LessWrong · Jun 12, 2026